Due to the special nature of medicines, returns and exchanges are not supported.
Final delivery from the nearest overseas warehous NEW

Niraparib 则乐 尼拉帕利

Niraparib (trade name in Hong Kong: Zele) is a highly effective and selective once-daily oral small molecule poly(ADP-ribose) PARP1/2 inhibitor for late-stage recurrent ovarian cancer. Maintenance therapy can significantly extend the survival period of patients with advanced ovarian cancer and reduce the recurrence of ovarian cancer.

Share:

Featured products

Laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor.